Edoxaban tosylate monohydrate

Category API

Details	Specifications
CAS Number	1229194-11-9
Molecular Formula	C31H40ClN7O8S2
Molecular Weight	738.27 g/mol.
Synonyms	Edoxaban tosylate hydrate
Chemical Name	N'-(5-chloro-2-pyridinyl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3] thiazolo[5,4-c] pyridine-2-carbonyl) amino] cyclohexyl] oxamide;4-methylbenzenesulfonic acid hydrate
Common name	Edoxaban tosylate
Therapeutic use	Anticoagulant (DOAC) used to reduce the risk of stroke in nonvalvular atrial fibrillation and treat deep vein thrombosis (DVT) or pulmonary embolism (PE)
Background	It was developed by [Daiichi Sankyo](https://en.wikipedia.org/wiki/Daiichi_Sankyo) and approved in July 2011, in Japan for prevention of [venous thromboembolisms](https://en.wikipedia.org/wiki/Venous_thromboembolism) following lower-limb [orthopedic surgery](https://en.wikipedia.org/wiki/Orthopedic_surgery). It was also approved in the United States by the [Food and Drug Administration](https://en.wikipedia.org/wiki/Food_and_Drug_Administration) (FDA) in January 2015, for the prevention of stroke and non–central-nervous-system systemic [embolism](https://en.wikipedia.org/wiki/Embolism). It was approved for use in the European Union in June 2015. It is on the [World Health Organization's List of Essential Medicines](https://en.wikipedia.org/wiki/WHO_Model_List_of_Essential_Medicines).
Grade	In-house
Polymorph	Form I
GTI	Risk assessment report available
Nitrosamines	Risk assessment report available
DMF Availability	-
Manufacturing batch size	-
Production capacity	-
Stability data	-

Please Note: We partner exclusively with pharmaceutical manufacturers, biotech companies, and international trading firms. Minimum order quantities apply*

Disclaimer:

The information provided on this webpage is based on the best available knowledge at the time of publication; however, accuracy and completeness are not guaranteed. Product specifications may change without notice. It is the responsibility of the purchaser or user to verify suitability and compliance. This product is intended for research use only and is not approved for human consumption.

Why Shilpa Pharma?

Happy Customers

Projects Successfully Completed

Established

PhD Experts Driving R&D Excellence

Team Size

World-Class API Manufacturing Sites

Global Audits Successfully Completed

Comprehensive CDMO Service Offerings

Our Edoxaban tosylate monohydrate are also Available for

Questions & Answers

FAQ on Edoxaban tosylate monohydrate

Everything You Need to Know About Shilpa Pharma

Shilpa Pharma – Your Trusted Global CDMO Partner

Delivering end-to-end solutions across API oncology, generics, peptides, polymers and specialty chemicals, we empower partners to accelerate development, ensure compliance, and reach markets faster with reliable, cost-effective innovation.